Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Chondrosarcoma × Glutamine × Clear all

Sponsor

Conditions

Peripheral Nervous System Diseases 3 Lymphoma 3 Lymphoma, Large B-Cell, Diffuse 2 Breast Neoplasms 2 Wilms Tumor 1 Vaso-Occlusive Crises 1 Sarcoma 1 Prostatic Neoplasms 1 Pain 1 Neurotoxicity Syndromes 1 Neuroectodermal Tumors, Primitive, Peripheral 1 Multiple Myeloma 1 Multiple Endocrine Neoplasia Type 1 1 Lymphoma, Non-Hodgkin 1 Lymphoma, Extranodal NK-T-Cell 1 Leukemia 1 Kidney Neoplasms 1 Dendritic Cell Sarcoma, Interdigitating 1 Burkitt Lymphoma 1 Anemia, Sickle Cell 1

Interventions

HhAntag691 2 toripalimab 1 temsirolimus 1 pegfilgrastim 1 pazopanib 1 liposomal doxorubicin 1 enasidenib 1 angiotensin I (1-7) 1 Sunitinib 1 Radiotherapy, Intensity-Modulated 1 Radiotherapy, Image-Guided 1 Radiotherapy, Conformal 1 Proton Therapy 1 Pharmacogenomic Testing 1 Microarray Analysis 1 Medicare Part B 1 Magnetic Resonance Spectroscopy 1 Immunologic Techniques 1 Gemcitabine 1 Filgrastim 1 Ferrosoferric Oxide 1 Fentanyl 1 Docetaxel 1 Dasatinib 1 Cyproheptadine 1 3-(8-amino-1-(2-phenylquinolin-7-yl)imidazo(1,5-a)pyrazin-3-yl)-1-methylcyclobutanol 1 2,2-dimethyl-N-(6-oxo-6,7-dihydro-5H-dibenzo(b,d)azepin-7-yl)-N'-(2,2,3,3,3-pentafluoropropyl)malonamide 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡